+1.45%
Today
Loading 1D prices…
Company profile
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Long Beach, CA, United States
Employees
613
Fiscal year end
1231
CIK
1818093
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LNSRLENSAR Inc. Common Stock | $93.4M | $51.7M | -66.36% | -$2.87 | -5.59% | Buy |
| MBOTMicrobot Medical Inc. Common Stock | $97.4M | $0.00 | — | -$0.29 | +0.34% | Buy |
| GUTSFractyl Health Inc. Common Stock | $101.9M | $0.00 | — | -$1.86 | -0.47% | Buy |
| LUNGPulmonx Corporation Common Stock | $79.5M | $90.5M | -59.67% | -$1.33 | +0.54% | Buy |
| PYPDPolyPid Ltd. Ordinary Shares | $104.6M | $0.00 | — | $2.09 | -0.19% | Buy |